ESC 365 - 24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

ESC Premium Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

Session: Recent advances in diagnosis/treatment of hypertension

Topic: Device Treatment and Intervention

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Associate Professor Daniil Maximkin

Peoples' Friendship University of Russia named after Patrice Lumumba, Moscow (Russian Federation)

0 follower

3 more presentations in this session

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Potential therapeutic efficacy via avB3-integrin dependent interaction of developmental endothelial locus-1 (Del-1) after established angiotensin-II dependent hypertension

Speaker: Mr M. Amponsah-Offeh (Mannheim, DE)

Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension

Speaker: Doctor A. Sukhareva (Tomsk, RU)

Access the full session

Recent advances in diagnosis/treatment of hypertension

Speakers: Associate Professor D. Maximkin, Doctor P. Kolkhof, Mr M. Amponsah-Offeh, Doctor A. Sukhareva

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources